Genetic markers within glutamate receptors associated with antidepressant treatment- emergent suicidal ideation

American Journal of Psychiatry

Volumn 165, Issue 7, 2008, Pages 917-918

  Menke, Andreas ^a   Lucae, Susanne ^a   Kloiber, Stefan ^a   Horstmann, Sonja ^a   Bettecken, Thomas ^a   Uhr, Manfred ^a   Ripke, Stephan ^a   Ising, Marcus ^a   Müller Myhsok, Bertram ^a   Holsboer, Florian ^a   Binder, Elisabeth B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR;

ALLELE; DEPRESSION; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; GRIA3 GENE; GRIK2 GENE; HAMILTON SCALE; HUMAN; LETTER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL IDEATION; X CHROMOSOME;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; GENETIC MARKERS; GENOTYPE; HUMANS; RECEPTORS, GLUTAMATE; SUICIDE, ATTEMPTED;

EID: 46749150020     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08020274     Document Type: Letter

References (5)

1. Angst J, Angst F, Gerber-Werder R, Gamma A: Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res 2005; 9:279-300
2. Licinio J, Wong ML: Depression, antidepressants and suicidality: a critical appraisal. Nat Rev Drug Discov 2005; 4:165-171
3. Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D, McMahon FJ: Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry 2007; 164:1530-1538
4. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC: Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007; 64:193-200
5. Kugaya A, Sanacora G: Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005; 10:808-819